topic

PROGRESS IN THE DEVELOPMENT OF SAFE AND EFFECTIVE TUBERCULOSIS VACCINES
Dereck Tait

BMJ Global Health Feb 2017, 2 (Suppl 2) A15; DOI: 10.1136/bmjgh-2016-000260.37
COMMUNITY ENGAGEMENT IN TB VACCINE RESEARCH AND DEVELOPMENT IN ZAMBIA
Hlatjwako Sibusiso, Olga Manda, Kristin Croucher, Anja Van Der Westhuizen, Isaac Mshanga

BMJ Global Health Feb 2017, 2 (Suppl 2) A16; DOI: 10.1136/bmjgh-2016-000260.38
EFFECT OF ARTESUNATE MONOTHERAPY ON PLASMODIUM FALCIPARUM IN VIVO GENOMIC EXPRESSION
Aminatou Kone, Antoine Dara, Amadou Niangaly, Indranil Sinha, David Brodin, Bakary Fofana, Souleymane Dama, Demba Dembele, Bakary Sidibe, Nouhoum Diallo, Mahamadou Thera, Issaka Sagara, Karin Wright, Anders Björkman, Jose Gil, Ogobara Doumbo, Abdoulaye Djimde

BMJ Global Health Feb 2017, 2 (Suppl 2) A17-A18; DOI: 10.1136/bmjgh-2016-000260.43
PF3D7_1343700 KELCH PROPELLER (K13-PROPELLER) POLYMORPHISMS AND ARTESUNATE MONOTHERAPY EFFICACY IN UNCOMPLICATED MALARIA TREATMENT IN MALI
Sekou Sissoko, Aminatou Kone, Bakary Fofana, Cheick Sangaré, Demba Dembele, Sekou Toure, Kassim Sanogo, Hamadoun Diakite, Siaka Toure, Diagassan Doumbia, Kadiatou Haidara, Ogobara Doumbo, Abdoulaye Djimde

BMJ Global Health Feb 2017, 2 (Suppl 2) A18; DOI: 10.1136/bmjgh-2016-000260.45
VARIABILITY IN CLINICAL RESEARCH DATA MANAGEMENT PRACTICES: LESSONS FROM THE MALARIA COMMUNITY
Amélie Julé, Hazel Ashurst, Laura Merson, Piero Olliaro, Vicki Marsh, Trudie Lang, Philippe Guérin

BMJ Global Health Feb 2017, 2 (Suppl 2) A19; DOI: 10.1136/bmjgh-2016-000260.46
DEFEATING POVERTY-RELATED AND NEGLECTED DISEASES IN AFRICA: HARNESSING RESEARCH FOR EVIDENCE-INFORMED POLICIES
Michael Makanga, Pauline Beattie, Gabrielle Breugelmans, Thomas Nyirenda, Moses Bockarie

BMJ Global Health Feb 2017, 2 (Suppl 2) A2; DOI: 10.1136/bmjgh-2016-000260.1
RE-EVALUATION OF MALARIA DIAGNOSIS BY MOLECULAR METHODS REVEALS MUTATIONS IN HRP-2 AND DRUG RESISTANCE MARKERS IN CAMEROON
Palmer Netongo, Séverin Kamdem, Thirumalaisamy Velavan, Peter Kremsner

BMJ Global Health Feb 2017, 2 (Suppl 2) A21-A22; DOI: 10.1136/bmjgh-2016-000260.54
CXCL10 GENE PROMOTER POLYMORPHISM – 1447A>G IS ASSOCIATED WITH MALARIA IN GHANAIAN CHILDREN
Felix Botchway, Nana Wilson, Carmen M Dickinson-Copeland, Andrew A. Adjei, Michael Wilson, Jonathan K. Stiles

BMJ Global Health Feb 2017, 2 (Suppl 2) A21; DOI: 10.1136/bmjgh-2016-000260.52
FOSMIDOMYCIN-PIPERAQUINE AS NON-ARTEMISININ-BASED COMBINATION FOR ACUTE UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Ghyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, Rella Zoleko Manego, Lilian Endamne, Bertrand Lell, David Hutchinson, Peter Kremsner

BMJ Global Health Feb 2017, 2 (Suppl 2) A22-A23; DOI: 10.1136/bmjgh-2016-000260.57
SEASONAL MALARIA CHEMOPREVENTION WITH SULPHADOXINE-PYRIMETHAMINE AND AMODIAQUINE SELECTS DHFR-DHPS QUINTUPLE MUTANT GENOTYPE IN MALI
Hamma Maiga, Estrella Lasry, Modibo Diarra, Issaka Sagara, Amadou Bamadio, Aliou Traore, Samba Coumare, Bahonan Soma, Yeyia Dicko, Nouhoum Diallo, Boubou Sangare, Aly Tembely, Djibril Traore, Hamidou Niangaly, François Dao, Aboubecrin Haidara, Alassane Dicko, Ogobara Doumbo, Abdoulaye Djimde

BMJ Global Health Feb 2017, 2 (Suppl 2) A22; DOI: 10.1136/bmjgh-2016-000260.55

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages